⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2026Open Access

A cell-based technological proposal for modernization and optimization of the 17DD yellow fever vaccine production

Tiago Santos Viviane Gomes Ygara Mendes Chun Shen Marin Loignon Luciane Gaspar Ana Duarte Mariana Gomes Renata Brício

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to propose a cell-based technology for modernizing and optimizing the production of the 17DD yellow fever vaccine.
Submission to the International Symposium on Immunobiologicals
Coordination by Bio-Manguinhos, Fundação Oswaldo Cruz
Proposed methodology could lead to more efficient vaccine production processes
Potential for increased yield and reduced production costs

Implication

Proposes a cell-based approach to enhance the yellow fever vaccine production process, indicating potential improvements.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Santos et al. (2026) studied this question.

synapsesocial.com/papers/6a1a7dc00307b78509430b68 https://doi.org/10.35259/isi.2026_76355

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1In silico design of dengue virus epitopes, recombinant antigens and scfv antibodies for serotype-specific diagnostic developmentOriginal Research · 2026
2Development and analytical qualification of a cell-based potency assay for mRNA COVID-19 vaccinesOriginal Research · 2026
3Development of an innovative educational strategy based on design thinking to strengthen dengue vaccine implementation in BrazilOriginal Research · 2026
4Cellular immunological mechanisms induced by messenger RNA vaccineOriginal Research · 2026
5Advancing the multivalent vaccine horizon: development of bicistronic self-amplifying RNA platforms for next-generation immunobiologicalsOriginal Research · 2026

Evaluation of a stabilizing agent in messenger RNA vaccines for logistical application in Brazil2026
Scaling up YFV 17DD virus to a 40-liter pilot-scale stirred-tank bioreactor at Bio-Manguinhos Pilot Plant2026
Bio-Manguinhos and new generation of vaccines: consolidation of mRNA-LNP production and evaluation of critical quality attributes at pilot scale2026